| |
SCHEDULE 1
Insertion of Paragraphs 1A and 1B in Schedule to Misuse of Drugs Act 1977
|
| |
Section 1
|
| |
1A. (a) Alfentanil
|
| |
(3-Amino-2,2-dimethylpropyl)4-aminobenzoate
|
| |
5-(2-Aminopropyl) indole
|
| |
1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-pentanone
|
| |
N-(1-Benzyl-4-piperidyl) propionanilide
|
| |
1-(4-Bromofuro[2,3-f][1]benzofuran-8-yl) propan-2-amine
|
| |
Carfentanil
|
| |
Cathinone
|
| |
3,4-Dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide
|
| |
Dihydroetorphine
|
| |
[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone
|
| |
Dimethocaine
|
| |
3-Dimethylheptyl-11-hydroxyhexahydrocannabinol
|
| |
Eticyclidine
|
| |
Etryptamine
|
| |
1-(2-Fluorophenyl)-2-methylaminopropan-1-one
|
| |
1-(3-Fluorophenyl)-2-methylaminopropan-1-one
|
| |
1-(4-Fluorophenyl)-2-methylaminopropan-1-one
|
| |
9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
|
| |
[9-Hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate
|
| |
N-Hydroxy-tenamphetamine
|
| |
4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine
|
| |
Khat (being the leaves of Catha edulis (Celastraceae))
|
| |
Lofentanil
|
| |
Methcathinone
|
| |
2-(3-Methoxyphenyl)-2-(ethylamino)cyclohexanone
|
| |
1-(4-Methoxyphenyl)-2-(methylamino)propan-1-one
|
| |
Methyl(2S,4aR,6aR,7R,10aS,10bR)-9-acetyloxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]iso-chromene-7-carboxylate and any product, whether natural or otherwise, including any plant or plant material of any kind or description, which contains any proportion of the said substance
|
| |
2-Methylamino-1-(3,4-methylenedioxyphenyl)butan-1-one
|
| |
2-Methylamino-1-(3,4-methylenedioxyphenyl)propan-1-one
|
| |
4-Methyl-aminorex
|
| |
(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl)-4-fluorobenzoate
|
| |
Methyl-2-[(2S,3S,7aS,12bS)-3-ethyl-7a-hydroxy-8-methoxy-2,3,4,6,7,12b-hexahydro-1H-indolo[2,3a]quinolizin-2-yl]-3-methoxyprop-2-enoate and any product, whether natural or otherwise, including any plant or plant material of any kind or description, which contains any proportion of the said substance
|
| |
Methyl-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b- octahydroindolo[2,3a]quinolizin-2-yl]-3-methoxyprop-2-enoate and any product, whether natural or otherwise, including any plant or plant material of any kind or description, which contains any proportion of the said substance
|
| |
α-Methyl-4-(methylthio)phenethylamine
|
| |
1-(4-Methylphenyl)-2-methylaminopropan-1-one
|
| |
Nabilone
|
| |
Oripavine
|
| |
Phencyclidine
|
| |
1-Phenylcyclohexylamine
|
| |
4-(1-Phenylcyclohexyl)morpholine
|
| |
1-Piperidinocyclohexanecarbonitrile
|
| |
Remifentanil
|
| |
Rolicyclidine
|
| |
Sufentanil
|
| |
Tapentadol
|
| |
Tenocyclidine
|
| |
N-[1-(2-Thenyl)-4-piperidyl]propionanilide
|
| |
4-[1-(2-Thienyl)cyclohexyl]morpholine
|
| |
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine
|
| |
Tilidine.
|
| |
(b) Any substance (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways:
|
| |
(i) by substitution in the phenyl ring to any extent with alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylenedioxy, haloalkyl or halo substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
|
| |
(ii) by substitution at the 2- or 3-position of the propanone side-chain with an alkyl substituent;
|
| |
(iii) by substitution at the nitrogen atom with one or more alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic structure.
|
| |
(c) Any substance structurally derived from 2-amino-1-propanone by substitution at the 1-position with any monocyclic, or fused-polycyclic ring system (not being a phenyl ring or alkylenedioxyphenyl ring system), whether or not the substance is further modified in any of the following ways:
|
| |
(i) by substitution in the ring system to any extent with alkyl, alkenyl, alkynyl, alkoxy, alkylthio, haloalkyl or halo substituents, whether or not further substituted in the ring system by one or more other univalent substituents;
|
| |
(ii) by substitution at the 3-position with an alkyl substituent;
|
| |
(iii) by substitution at the 2-amino nitrogen atom with one or more alkyl or dialkyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure.
|
| |
(d) Any substance structurally derived from 3-(1-benzoyl)indole or 3-(1-naphthoyl)indole by modification in any of the following ways:
|
| |
(i) by substitution at the nitrogen atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl;
|
| |
(ii) by replacement of one or more hydrogen atoms of any of the substituents referred to in clause (i), with a halo substituent;
|
| |
whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl or naphthyl ring to any extent.
|
| |
(e) 1-Benzylpiperazine or any substance structurally derived from 1-benzylpiperazine or 1-phenylpiperazine by modification in any of the following ways:
|
| |
(i) by substitution at the second nitrogen atom of the piperazine ring with alkyl, benzyl, haloalkyl or phenyl groups;
|
| |
(ii) by substitution in the aromatic ring to any extent with alkyl, alkoxy, alkylenedioxy, halide or haloalkyl groups.
|
| |
(f) Any substance structurally derived from fentanyl by modification in one or more of the following ways, that is to say:
|
| |
(i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;
|
| |
(ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;
|
| |
(iii) by substitution in the piperidine ring with alkyl or alkenyl groups;
|
| |
(iv) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;
|
| |
(v) by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;
|
| |
(vi) by replacement of the N-propionyl group by another acyl group.
|
| |
(g) Any substance structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the cyclohexyl ring to any extent.
|
| |
(h) Any substance structurally derived from 3-(1-naphthoyl)indoleor 1H-indol-3-yl-(1-naphthyl) methane by substitution at the nitrogen atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
|
| |
(i) Any substance structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
|
| |
(j) Any substance structurally derived from 1-(1-naphthylmethyl)indene by substitution at the 3-position of the indene ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.
|
| |
(k) Any substance structurally derived from pethidine by modification in one or more of the following ways, that is to say:
|
| |
(i) by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;
|
| |
(ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;
|
| |
(iii) by substitution in the 4-phenyl ring with alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;
|
| |
(iv) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;
|
| |
(v) by formation of an N-oxide or a quaternary base.
|
| |
(l) Any substance (not being methoxyphenamine) structurally derived from phenethylamine, an N-alkyl-phenethylamine, α-methylphenethylamine, an N-alkyl-α-methylphenethylamine, α-ethylphenethylamine, or an N-alkyl-α-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halo substituents, whether or not further substituted in the ring by one or more other univalent substituents.
|
| |
(m) Any substance structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.
|
| |
(n) Any fungus containing any proportion of psilocin or of an ester of psilocin.
|
| |
(o) 1,2,3,4-Tetrahydronaphthalen-2-amine, 1,2-dihydronaphthalen-2-amine or 2,3-dihydro-1H-inden-2-amine or any substance structurally derived from 1,2,3,4-tetrahydronaphthalen-2-amine, 1,2-dihydronaphthalen-2-amine or 2,3-dihydro-1H-inden-2-amine by modification in any of the following ways:
|
| |
(i) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkenyl, alkynyl, alkylthio, alkylenedioxy, haloalkyl, hydroxy or halo substituents, whether or not further substituted by one or more other univalent substituents;
|
| |
(ii) by mono - or di-substitution at the nitrogen atom with alkyl, alkenyl, alkynyl or haloalkyl groups or by inclusion of the nitrogen atom in a cyclic structure.
|
| |
(p) Any substance structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the side-chain with one or more alkyl substituents but no other substituent.
|
| |
1B. (a) Alprazolam
|
| |
Amineptine
|
| |
Aminorex
|
| |
Amphetaminil
|
| |
2-Benzhydrylpiperidine
|
| |
Bromazepam
|
| |
Brotizolam
|
| |
Buprenorphine
|
| |
Butan-1,4-diol
|
| |
Butorphanol
|
| |
Camazepam
|
| |
Cathine
|
| |
Chlordiazepoxide
|
| |
Clobazam
|
| |
Clonazepam
|
| |
Clorazepic acid
|
| |
Clotiazepam
|
| |
Cloxazolam
|
| |
Delorazepam
|
| |
Dextropropoxyphene
|
| |
Diazepam
|
| |
Diethylpropion
|
| |
Dihydrofuran-2(3H)-one
|
| |
Estazolam
|
| |
Ethchlorvnol
|
| |
Ethinamate
|
| |
N-Ethylamphetamine
|
| |
Ethyl loflazepate
|
| |
Fencamfamin
|
| |
Fenethylline
|
| |
Fenproporex
|
| |
Fludiazepam
|
| |
Flunitrazepam
|
| |
Flurazepam
|
| |
Glutethimide
|
| |
Halazepam
|
| |
Haloxazolam
|
| |
4-Hydroxybutanoic acid
|
| |
Ketamine
|
| |
Ketazolam
|
| |
Lefetamine
|
| |
Loprazolam
|
| |
Lorazepam
|
| |
Lormetazepam
|
| |
Mazindol
|
| |
Mecloqualone
|
| |
Medazepam
|
| |
Mefenorex
|
| |
Meprobamate
|
| |
Mesocarb
|
| |
Methyprylone
|
| |
Midazolam
|
| |
Nalbuphine
|
| |
Nimetazepam
|
| |
Nitrazepam
|
| |
Nordazepam
|
| |
Oxazepam
|
| |
Oxazolam
|
| |
Pemoline
|
| |
Pentazocine
|
| |
Phentermine
|
| |
Pinazepam
|
| |
Prazepam
|
| |
Propylhexedrine
|
| |
Pyrovalerone
|
| |
Selegiline
|
| |
Temazepam
|
| |
Tetrazepam
|
| |
Triazolam
|
| |
Zipeprol
|
| |
Zolpidem.
|
| |
(b) Any substance structurally derived from barbituric acid by di-substitution at the 5-position, whether or not there is also substitution at the 1-position by a methyl substituent.
|
